{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:40:38Z","timestamp":1778301638207,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.aprim.2022.102362","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T14:44:12Z","timestamp":1656427452000},"page":"102362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tratamiento farmacol\u00f3gico de la insuficiencia card\u00edaca seg\u00fan la fracci\u00f3n de eyecci\u00f3n ventricular en atenci\u00f3n primaria"],"prefix":"10.1016","volume":"54","author":[{"given":"Maria","family":"Giner-Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dioselina","family":"D\u00edaz Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainhoa","family":"Gomez-Lumbreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Morros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2022.102362_bib0200","first-page":"1","article-title":"Estad\u00edstica de defunciones seg\u00fan la causa de muerte. Enero-mayo 2019 y 2020","year":"2021","journal-title":"INE Notas de prensa."},{"key":"10.1016\/j.aprim.2022.102362_bib0205","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ejhf.549","article-title":"Medical resource ue and expenditure in patients with chronic heart failure: A population-based analysis of 88 195 patients","volume":"18","author":"Farr\u00e9","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.aprim.2022.102362_bib0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.gaceta.2017.05.017","article-title":"An\u00e1lisis poblacional del gasto en servicios sanitarios en Catalu\u00f1a (Espa\u00f1a): \u00bfqu\u00e9 y qui\u00e9n consume m\u00e1s recursos?","volume":"33","author":"Vela","year":"2019","journal-title":"Gac Sanit"},{"key":"10.1016\/j.aprim.2022.102362_bib0215","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: A population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2022.102362_bib0220","first-page":"e.139","article-title":"Heart disease and stroke statistics\u20142020 update: A report from the American Heart Association","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.aprim.2022.102362_bib0225","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global Public Health Burden of Heart Failure","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.aprim.2022.102362_bib0230","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aprim.2022.102362_bib0235","doi-asserted-by":"crossref","first-page":"721.e3","DOI":"10.1016\/j.ahj.2014.07.008","article-title":"Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population","volume":"168","author":"Cheng","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.aprim.2022.102362_bib0240","unstructured":"Grupo de trabajo de la Gu\u00eda de Pr\u00e1ctica Cl\u00ednica sobre Tratamiento de la Insuficiencia Card\u00edaca Cr\u00f3nica. Gu\u00eda de Pr\u00e1ctica Cl\u00ednica sobre el Tratamiento de Insuficiencia Card\u00edaca Cr\u00f3nica. Minist Sanidad, Serv Soc e Igualdad Unidad Evaluaci\u00f3n Tecnol Sanit la Comunidad Madrid. 2016. Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el SNS."},{"key":"10.1016\/j.aprim.2022.102362_bib0245","article-title":"Chronic heart failure in adults: diagnosis and management","volume":"30","year":"2019","journal-title":"NICE, National Institute for Health and Care Excellence."},{"key":"10.1016\/j.aprim.2022.102362_bib0250","first-page":"1","year":"2016","journal-title":"Informe de Posicionamiento Terap\u00e9utico de sacubitrilo\/valsart\u00e1n (Entresto\u00ae) en el tratamiento de la insuficiencia cardiaca cr\u00f3nica sintom\u00e1tica en pacientes adultos con fracci\u00f3n de eyecci\u00f3n reducida"},{"key":"10.1016\/j.aprim.2022.102362_bib0255","unstructured":"Barcelona: Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya. Servei Catal\u00e0 de la Salut. Departament de Salut. Generalitat de Catalunya. Ivabradina. Tractament de la insufici\u00e8ncia card\u00edaca cr\u00f2nica de classe II-IV de la New York Heart Association amb disfunci\u00f3 sist\u00f2lica, en pacients en ritme sinusal i amb freq\u00fc\u00e8ncia card\u00edaca de>75 batecs per minut (bpm), en associaci\u00f3 amb el tractament est. 2013;."},{"key":"10.1016\/j.aprim.2022.102362_bib0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.recesp.2011.07.017","article-title":"Validez del Sistema de Informaci\u00f3n para el Desarrollo de la Investigaci\u00f3n en Atenci\u00f3n Primaria (SIDIAP) en el estudio de enfermedades vasculares: estudio EMMA","volume":"65","author":"Ramos","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.aprim.2022.102362_bib0265","unstructured":"Barcelona: Servei Catal\u00e0 de la Salut. Departament de Salut. Generalitat de Catalunya. Programa d\u2019harmonitzaci\u00f3 farmacoterap\u00e8utica. Dapagliflozina per al tractament de la insufici\u00e8ncia card\u00edaca cr\u00f2nica amb fracci\u00f3 d\u2019ejecci\u00f3 redu\u00efda. 2021."},{"key":"10.1016\/j.aprim.2022.102362_bib0270","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-021-10186-7","article-title":"Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions","author":"Passantino","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.aprim.2022.102362_bib0275","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aprim.2022.102362_bib0280","unstructured":"SIDIAP. SIDIAP. Information system for research in Primary Care. SIDIAP. 2022 [consultado Nov 2020]. Disponible en: http:\/\/www.sidiap.org\/index.php\/en"},{"key":"10.1016\/j.aprim.2022.102362_bib0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1157\/13123961","article-title":"Construcci\u00f3n de un \u00edndice de privaci\u00f3n a partir de datos censales en grandes ciudades espa\u00f1olas (Proyecto MEDEA)","volume":"22","author":"Dom\u00ednguez-Berj\u00f3n","year":"2008","journal-title":"Gac Sanit"},{"key":"10.1016\/j.aprim.2022.102362_bib0290","unstructured":"WHO. ICD-10 Version: 2019 International Statistical Classification of diseases and Related Health Problems 10th Revision. 2019 [consultado Ago 2020]. Disponible en: https:\/\/icd.who.int\/browse10\/2019\/en"},{"key":"10.1016\/j.aprim.2022.102362_bib0295","year":"2019","journal-title":"ATC\/DDD Index 2019."},{"key":"10.1016\/j.aprim.2022.102362_bib0300","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: A gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann Stat"},{"key":"10.1016\/j.aprim.2022.102362_bib0305","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchf.2018.11.019","article-title":"Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure","volume":"7","author":"Savarese","year":"2019","journal-title":"JACC Hear Fail"},{"key":"10.1016\/j.aprim.2022.102362_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2017-018719","article-title":"Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: A multicentre prospective observational study in Catalonia (Spain)","volume":"7","author":"Farr\u00e9","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.aprim.2022.102362_bib0315","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2018.09.021","article-title":"Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation","volume":"123","author":"Mir\u00f3","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.aprim.2022.102362_bib0320","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.aprim.2022.102362_bib0325","doi-asserted-by":"crossref","first-page":"300","DOI":"10.36660\/abc.20190912","article-title":"Artigo Original Caracter\u00edsticas e Tend\u00eancias na Mortalidade em Diferentes Fen\u00f3tipos de Insufici\u00eancia Card\u00edaca na Aten\u00e7\u00e3o Prim\u00e1ria","volume":"117","author":"Lagoeiro Jorge","year":"2021","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.aprim.2022.102362_bib0330","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ejhf.1058","article-title":"What have we learned about heart failure with mid-range ejection fraction one year after its introduction?","volume":"19","author":"Nauta","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.aprim.2022.102362_bib0335","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.aprim.2022.102362_bib0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ahj.2020.06.002","article-title":"A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry","volume":"227","author":"Joseph","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.aprim.2022.102362_bib0345","first-page":"687","article-title":"Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: A systematic review and meta-analysis","volume":"5","author":"Lauritsen","year":"2018","journal-title":"ESC Hear Fail"},{"issue":"2P1","key":"10.1016\/j.aprim.2022.102362_bib0350","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcmg.2017.11.017","article-title":"Assessment of Left Ventricular Function by Echocardiography: The Case for Routinely Adding Global Longitudinal Strain to Ejection Fraction","volume":"11","author":"Potter","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.aprim.2022.102362_bib0355","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/clc.22468","article-title":"Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review","volume":"38","author":"Yap","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.aprim.2022.102362_bib0360","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ejhf.471","article-title":"The real-world evidence of heart failure: Findings from 41 413 patients of the ARNO database","volume":"18","author":"Maggioni","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.aprim.2022.102362_bib0365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.442","article-title":"Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: A systematic review","volume":"18","author":"Vaduganathan","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.aprim.2022.102362_bib0370","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: Insights from the framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.aprim.2022.102362_bib0375","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2022.102362_bib0380","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.aprim.2022.102362_bib0385","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.medcli.2012.01.020","article-title":"SIDIAP database: Electronic clinical records in primary care as a source of information for epidemiologic research","volume":"138","author":"Bol\u00edbar","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2022.102362_bib0390","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ejhf.1091","article-title":"Predictors and outcomes of heart failure with mid-range ejection fraction","volume":"20","author":"Bhambhani","year":"2018","journal-title":"Eur J Heart Fail"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:02:37Z","timestamp":1759323757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656722000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0212656722000828"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102362","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento farmacol\u00f3gico de la insuficiencia card\u00edaca seg\u00fan la fracci\u00f3n de eyecci\u00f3n ventricular en atenci\u00f3n primaria","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102362"}}